ArticleJournal of neurosurgery. Case lessons2025
Is there an optimal sequencing of endoscopic third ventriculostomy and stereotactic radiosurgery for brain metastasis with secondary obstructive hydrocephalus? Illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSecondary hydrocephalus caused by tumor obstruction of the aqueduct leads to anatomical distortion of the third ventricle (3V) and the surrounding structures. This report quantifies and discusses the dosimetric impact of hydrocephalus in stereotactic radiosurgery (SRS) treatment and discusses the optimal sequencing between radiosurgery and endoscopic third ventriculostomy (ETV). OBSERVATIONS: The authors review a case of intracranial metastasis causing secondary obstructive hydrocephalus that underwent ETV before SRS. Dual SRS plans were made based on the MRI before and after the ETV to evaluate the impact of the ventricular volume on dosimetry. Both plans had the same treatment parameters. The time interval between the MRI studies was approximately 20 days, with a 74% increase in the tumor size. The post-ETV plan revealed a reduced ventricular volume, particularly the 3V, with a noticeable shift in normal brain structures, leading them to receive increased doses. LESSONS: The anatomical changes caused by the ventricular reduction after the ETV associated with the tumor growth were enough to produce a higher dose to the healthy tissue, exposing the patient to a greater risk of adverse radiation effects. Shortening the interval between ETV and SRS can minimize anatomical shifts and the risk of adverse effects while maintaining adequate patient management. https://thejns.org/doi/10.3171/CASE25275.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.